Vitamin D Deficiency, Inflammation, and Albuminuria in Chronic Kidney Disease: Complex Interactions

Li, 2010, Renoprotective effects of vitamin D analogs, Kidney Int, 78, 134, 10.1038/ki.2009.175

Agarwal, 2009, Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD, Clin J Am Soc Nephrol, 4, 1523, 10.2215/CJN.02010309

Li, 2002, 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system, J Clin Invest, 110, 229, 10.1172/JCI0215219

Xiang, 2005, Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems, Am J Physiol Endocrinol Metab, 288, E125, 10.1152/ajpendo.00224.2004

Bodyak, 2007, Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals, Proc Natl Acad Sci U S A, 104, 16810, 10.1073/pnas.0611202104

Liu, 2006, Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response, Science, 311, 1770, 10.1126/science.1123933

Dobnig, 2008, Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality, Arch Intern Med, 168, 1340, 10.1001/archinte.168.12.1340

Moe, 2006, Vascular calcification and renal osteodystrophy relationship in chronic kidney disease, Eur J Clin Invest, 36, 51, 10.1111/j.1365-2362.2006.01665.x

Block, 2004, Mineral metabolism, mortality, and morbidity in maintenance hemodialysis, J Am Soc Nephrol, 15, 2208, 10.1097/01.ASN.0000133041.27682.A2

Ganesh, 2001, Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients, J Am Soc Nephrol, 12, 2131, 10.1681/ASN.V12102131

London, 2007, Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency, J Am Soc Nephrol, 18, 613, 10.1681/ASN.2006060573

Menon, 2005, C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease, Kidney Int, 68, 766, 10.1111/j.1523-1755.2005.00455.x

Schiffrin, 2007, Chronic kidney disease: effects on the cardiovascular system, Circulation, 116, 85, 10.1161/CIRCULATIONAHA.106.678342

Gerstein, 2001, Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals, JAMA, 286, 421, 10.1001/jama.286.4.421

Brenner, 2001, Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N Engl J Med, 345, 861, 10.1056/NEJMoa011161

Levin, 2007, Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease, Kidney Int, 71, 31, 10.1038/sj.ki.5002009

2003, K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease, Am J Kidney Dis, 42, S1, 10.1016/S0272-6386(03)00905-3

Remuzzi, 1998, Pathophysiology of progressive nephropathies, N Engl J Med, 339, 1448, 10.1056/NEJM199811123392007

de Boer, 2007, 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III), Am J Kidney Dis, 50, 69, 10.1053/j.ajkd.2007.04.015

Agarwal, 2005, Antiproteinuric effect of oral paricalcitol in chronic kidney disease, Kidney Int, 68, 2823, 10.1111/j.1523-1755.2005.00755.x

Wolf, 2007, Vitamin D levels and early mortality among incident hemodialysis patients, Kidney Int, 72, 1004, 10.1038/sj.ki.5002451

Lambers Heerspink, 2009, The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics, Am J Nephrol, 30, 280, 10.1159/000225903